Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases

Clinical trial NCT00238251 · COMPLETED

Trial details

NCT number: NCT00238251
Sponsor: Swiss Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer Metastatic Cancer

Start date: 2005-05-01
Primary completion: 2009-04-01
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.